Patients with TPX2 elevated expression were likely to be sensitive to many anticancer drugs based on the Cancer Therapeutics Response Portal (CTRP) and Genomics of Drug Sensitivity in Cancer (GDSC) database (Figure 11B, 11C). This evidence concerns the gene TPX2 and cancer.